Literature DB >> 16260757

Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils.

Charles Galea1, Prentice Bowman, Richard W Kriwacki.   

Abstract

We describe in molecular detail how disruption of an intermonomer salt bridge (Arg337-Asp352) leads to partial destabilization of the p53 tetramerization domain and a dramatically increased propensity to form amyloid fibrils. At pH 4.0 and 37 degrees C, a p53 tetramerization domain mutant (p53tet-R337H), associated with adrenocortical carcinoma in children, readily formed amyloid fibrils, while the wild-type (p53tet-wt) did not. We characterized these proteins by equilibrium denaturation, 13C(alpha) secondary chemical shifts, (1H)-15N heteronuclear NOEs, and H/D exchange. Although p53tet-R337H was thermodynamically less stable, NMR data indicated that the two proteins had similar secondary structure and molecular dynamics. NMR derived pK(a) values indicated that at low pH the R337H mutation partially disrupted an intermonomer salt bridge. Backbone H/D exchange results showed that for at least a small population of p53tet-R337H molecules disruption of this salt bridge resulted in partial destabilization of the protein. It is proposed that this decrease in p53tet-R337H stability resulted in an increased propensity to form amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260757      PMCID: PMC2253254          DOI: 10.1110/ps.051622005

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  55 in total

Review 1.  Amyloid fibrillogenesis: themes and variations.

Authors:  J C Rochet; P T Lansbury
Journal:  Curr Opin Struct Biol       Date:  2000-02       Impact factor: 6.809

2.  A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro.

Authors:  M Ramirez-Alvarado; J S Merkel; L Regan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 3.  Amyloid fibril proteins.

Authors:  Yanming Xing; Keiichi Higuchi
Journal:  Mech Ageing Dev       Date:  2002-11       Impact factor: 5.432

Review 4.  The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein.

Authors:  J W Conaway; T Kamura; R C Conaway
Journal:  Biochim Biophys Acta       Date:  1998-04-17

5.  Structure and functionality of a designed p53 dimer.

Authors:  T S Davison; X Nie; W Ma; Y Lin; C Kay; S Benchimol; C H Arrowsmith
Journal:  J Mol Biol       Date:  2001-03-23       Impact factor: 5.469

Review 6.  Oligomerizaiton and fibril asssembly of the amyloid-beta protein.

Authors:  A E Roher; J Baudry; M O Chaney; Y M Kuo; W B Stine; M R Emmerling
Journal:  Biochim Biophys Acta       Date:  2000-07-26

7.  A meanfield approach to the thermodynamics of a protein-solvent system with application to the oligomerization of the tumor suppressor p53.

Authors:  J Noolandi; T S Davison; A R Volkel; X Nie; C Kay; C H Arrowsmith
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

8.  Effect of the N1 residue on the stability of the alpha-helix for all 20 amino acids.

Authors:  D A Cochran; S Penel; A J Doig
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

9.  Relationship between ion pair geometries and electrostatic strengths in proteins.

Authors:  Sandeep Kumar; Ruth Nussinov
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

10.  Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.

Authors:  Amanda S Lee; Charles Galea; Enrico L DiGiammarino; Bokkyoo Jun; Gopal Murti; Raul C Ribeiro; Gerard Zambetti; Christian P Schultz; Richard W Kriwacki
Journal:  J Mol Biol       Date:  2003-03-28       Impact factor: 5.469

View more
  13 in total

Review 1.  Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.

Authors:  Kanaga Sabapathy; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2017-09-26       Impact factor: 66.675

Review 2.  The tumor suppressor p53: from structures to drug discovery.

Authors:  Andreas C Joerger; Alan R Fersht
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-02-10       Impact factor: 10.005

Review 3.  Potential of rescue and reactivation of tumor suppressor p53 for cancer therapy.

Authors:  Emi Hibino; Hidekazu Hiroaki
Journal:  Biophys Rev       Date:  2022-01-11

4.  The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Authors:  Ariele Viacava Follis; Fabien Llambi; Li Ou; Katherine Baran; Douglas R Green; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

5.  A fluid salt-bridging cluster and the stabilization of p53.

Authors:  Thu Zar Lwin; Jason J Durant; Donald Bashford
Journal:  J Mol Biol       Date:  2007-08-24       Impact factor: 5.469

6.  Large-scale analysis of thermostable, mammalian proteins provides insights into the intrinsically disordered proteome.

Authors:  Charles A Galea; Anthony A High; John C Obenauer; Ashutosh Mishra; Cheon-Gil Park; Marco Punta; Avner Schlessinger; Jing Ma; Burkhard Rost; Clive A Slaughter; Richard W Kriwacki
Journal:  J Proteome Res       Date:  2009-01       Impact factor: 4.466

7.  Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer.

Authors:  Ana P D Ano Bom; Luciana P Rangel; Danielly C F Costa; Guilherme A P de Oliveira; Daniel Sanches; Carolina A Braga; Lisandra M Gava; Carlos H I Ramos; Ana O T Cepeda; Ana C Stumbo; Claudia V De Moura Gallo; Yraima Cordeiro; Jerson L Silva
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

8.  Searching for factors that distinguish disease-prone and disease-resistant prions via sequence analysis.

Authors:  Kanaka Durga Kedarisetti; Scott Dick; Lukasz Kurgan
Journal:  Bioinform Biol Insights       Date:  2008-03-12

Review 9.  Molecular dynamic simulation insights into the normal state and restoration of p53 function.

Authors:  Ting Fu; Hanyi Min; Yong Xu; Jianzhong Chen; Guohui Li
Journal:  Int J Mol Sci       Date:  2012-08-03       Impact factor: 6.208

10.  Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.

Authors:  Jennifer J Jordan; Daniel Menendez; Alberto Inga; Maher Noureddine; Maher Nourredine; Douglas A Bell; Douglas Bell; Michael A Resnick
Journal:  PLoS Genet       Date:  2008-06-27       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.